EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Open Access

Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis

Danilo Menichelli iD, Emilia Antonucci iD, Gianluca Gazzaniga iD, Daniela Poli iD, Giuseppe Armentaro iD, Giordano di Carlo, Rossella Marcucci iD, Paolo Calabrò iD, Arturo Cesaro iD, Gualtiero Palareti iD, Angela Sciacqua, Pasquale Pignatelli iD und 2 weitere

Journal of the American Heart Association · 17.06.2025 · 14 (12)

DOI: 10.1161/jaha.125.042586 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Journal of the American Heart Association, erschienen am 17.06.2025. Verfasst von Danilo Menichelli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and Surgical Specialty Paride Stefanini Sapienza University of Rome Rome Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on atrial fibrillation (AF) and heart failure (HF) with preserved ejection fraction (HFpEF) are scarce. We investigated the association of HFpEF with all‐cause mortality in AF.

Methods

We included 10 369 patients with AF on oral anticoagulants from the nationwide ongoing START (Survey on Anticoagulated Patients Register) registry. Patients were divided into 3 groups: (1) no HF, (2) HF with reduced EF/HF with mildly reduced EF (EF ≤50%), and HFpEF (EF >50%). Patients with HF should have had a clinical diagnosis or a history of HF hospitalization. The association between HF types and all‐cause mortality was investigated by Cox proportional hazards regression analysis to estimate hazard ratio (HR) and 95% CI for each factor. The Fine–Gray model and propensity score matching were used.

Results

Mean age was 76.4±9.4 years and 45.8% were women. Overall, 2309 (22.2%) patients had HF, of whom 47.4% had HFpEF. During 720±576 days of follow‐up (20 747 patients/year), 727 deaths occurred (3.5 per 100 patient‐years). After propensity score matching, both HF with mildly reduced EF/HF with reduced EF and HFpEF were associated with all‐cause mortality (HR, 1.33; P =0.037 and HR, 1.49; P =0.004). HFpEF was associated with mortality in men (HR, 1.654; P =0.001) but not in women (HR, 1.243; P =0.175). In HFpEF, age≥75 years (HR, 2.247; P =0.003), chronic respiratory disease (HR, 2.109; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureAgedAged, 80 and overFemaleHumansMaleAnticoagulantsCause of DeathPhenotypePropensity ScoreRegistriesRisk AssessmentRisk FactorsStroke Volume

Stichwörter der Autor:innen

AFHFpEFHFrEF/HFmrEFatrial fibrillationheart failuremortality

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of General Surgery and Surgical Specialty Paride Stefanini Sapienza University of Rome Rome Italy.
  • Fondazione Arianna Anticoagulazione Bologna Italy.
  • Center of Atherothrombotic Disease Azienda Ospedaliero-Universitaria Careggi Florence Italy.
  • Department of Medical and Surgical Sciences University Magna Græcia of Catanzaro Catanzaro Italy.
  • Postgraduate School of Internal Medicine, Department of Internal Medicine and Medical Specialties Sapienza University of Rome Rome Italy.
  • Department of Clinical and Experimental Medicine University of Florence Florence Italy.

ORCID-Profile: Danilo Menichelli, Emilia Antonucci, Gianluca Gazzaniga, Daniela Poli, Giuseppe Armentaro, Rossella Marcucci, Paolo Calabrò, Arturo Cesaro, Gualtiero Palareti, Pasquale Pignatelli, Daniele Pastori

Zitieren

APA

Menichelli, D., Antonucci, E., Gazzaniga, G., Poli, D., Armentaro, G., di Carlo, G., Marcucci, R., Calabrò, P., Cesaro, A., Palareti, G., Sciacqua, A., Pignatelli, P., Pastori, D., & START 2 Collaborators * (2025). Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis. Journal of the American Heart Association, 14(12). https://doi.org/10.1161/jaha.125.042586

Vancouver

Menichelli D, Antonucci E, Gazzaniga G, Poli D, Armentaro G, di Carlo G, et al. Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis. Journal of the American Heart Association. 2025;14(12). doi:10.1161/jaha.125.042586

BibTeX
@article{Menichelli2025,
  author = {Menichelli, Danilo and Antonucci, Emilia and Gazzaniga, Gianluca and Poli, Daniela and Armentaro, Giuseppe and di Carlo, Giordano and Marcucci, Rossella and Calabrò, Paolo and Cesaro, Arturo and Palareti, Gualtiero and Sciacqua, Angela and Pignatelli, Pasquale and Pastori, Daniele and START 2 Collaborators *, START 2 Collaborators *},
  title = {Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {12},
  doi = {10.1161/jaha.125.042586}
}
Kostenlos starten →